268 related articles for article (PubMed ID: 25462557)
1. Virtual screening in small molecule discovery for epigenetic targets.
Li GB; Yang LL; Yuan Y; Zou J; Cao Y; Yang SY; Xiang R; Xiang M
Methods; 2015 Jan; 71():158-66. PubMed ID: 25462557
[TBL] [Abstract][Full Text] [Related]
2. Quantitative structure-activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries.
Pham-The H; Casañola-Martin G; Diéguez-Santana K; Nguyen-Hai N; Ngoc NT; Vu-Duc L; Le-Thi-Thu H
SAR QSAR Environ Res; 2017 Mar; 28(3):199-220. PubMed ID: 28332438
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel potential scaffold for class I HDACs inhibition: An in-silico protocol based on virtual screening, molecular dynamics, mathematical analysis and machine learning.
Fan C; Huang Y
Biochem Biophys Res Commun; 2017 Sep; 491(3):800-806. PubMed ID: 28705738
[TBL] [Abstract][Full Text] [Related]
4. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
[TBL] [Abstract][Full Text] [Related]
5. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic drugs that do not target enzyme activity.
Owen DR; Trzupek JD
Drug Discov Today Technol; 2014 Jun; 12():e29-34. PubMed ID: 25027371
[TBL] [Abstract][Full Text] [Related]
7. A structure-based virtual screening approach toward the discovery of histone deacetylase inhibitors: identification of promising zinc-chelating groups.
Park H; Kim S; Kim YE; Lim SJ
ChemMedChem; 2010 Apr; 5(4):591-7. PubMed ID: 20157916
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.
Furdas SD; Kannan S; Sippl W; Jung M
Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a series of small molecules as potent histone deacetylase inhibitors.
Zhang L; Wang X; Li X; Xu W
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):333-7. PubMed ID: 23534931
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Virtual Screening.
Li Q; Shah S
Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
[TBL] [Abstract][Full Text] [Related]
12. Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validation.
Kannan S; Melesina J; Hauser AT; Chakrabarti A; Heimburg T; Schmidtkunz K; Walter A; Marek M; Pierce RJ; Romier C; Jung M; Sippl W
J Chem Inf Model; 2014 Oct; 54(10):3005-19. PubMed ID: 25243797
[TBL] [Abstract][Full Text] [Related]
13. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
Bayo J; Dalvi MP; Martinez ED
Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
[TBL] [Abstract][Full Text] [Related]
14. Discovery and development of DNA methyltransferase inhibitors using in silico approaches.
Medina-Franco JL; Méndez-Lucio O; Dueñas-González A; Yoo J
Drug Discov Today; 2015 May; 20(5):569-77. PubMed ID: 25526932
[TBL] [Abstract][Full Text] [Related]
15. Molecular fingerprint similarity search in virtual screening.
Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Garcia-Vallvé S; Pujadas G
Methods; 2015 Jan; 71():58-63. PubMed ID: 25132639
[TBL] [Abstract][Full Text] [Related]
16. A lazy learning-based QSAR classification study for screening potential histone deacetylase 8 (HDAC8) inhibitors.
Cao GP; Arooj M; Thangapandian S; Park C; Arulalapperumal V; Kim Y; Kwon YJ; Kim HH; Suh JK; Lee KW
SAR QSAR Environ Res; 2015; 26(5):397-420. PubMed ID: 25986171
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic assays for chemical biology and drug discovery.
Gul S
Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
[TBL] [Abstract][Full Text] [Related]
18. Computer- and structure-based lead design for epigenetic targets.
Heinke R; Carlino L; Kannan S; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3605-15. PubMed ID: 21316248
[TBL] [Abstract][Full Text] [Related]
19. Hierarchical virtual screening approaches in small molecule drug discovery.
Kumar A; Zhang KY
Methods; 2015 Jan; 71():26-37. PubMed ID: 25072167
[TBL] [Abstract][Full Text] [Related]
20. BEAR, a novel virtual screening methodology for drug discovery.
Degliesposti G; Portioli C; Parenti MD; Rastelli G
J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
